Related Experiment Videos

[Potential of selenium in gynecologic oncology]

A M Funke1

  • 1Universitäts-Frauenklinik Köln. bonn.anna.funke.dr@t-online.de

Medizinische Klinik (Munich, Germany : 1983)
|November 11, 1999
PubMed
Abstract

Insights

Selenium supplementation shows promise in improving quality of life for gynecologic cancer patients. Low-dose sodium selenite may reduce treatment side effects and boost immune function, with no reported adverse events in pilot studies.

Area of Science:

  • Oncology
  • Nutritional Science
  • Immunology

Context:

  • Previous large-scale studies found no clear preventive benefits of selenium supplementation for female cancers in industrialized nations.
  • Existing research on selenium's therapeutic effects in gynecologic oncology is limited.
  • Patients with gynecologic and breast cancers often seek complementary natural medicine therapies.

Purpose:

  • To investigate the therapeutic potential of low-dose sodium selenite in gynecologic oncology.
  • To evaluate the impact of selenium supplementation on quality of life and immune function in cancer patients.
  • To explore selenium's role in mitigating side effects of conventional cancer treatments.

Summary:

  • Pilot studies using low-dose sodium selenite (up to 300 micrograms/day) in patients with gynecologic and breast cancers reported improved quality of life.
  • No adverse side effects were reported in these pilot studies.
  • Immune system analysis indicated stimulation of B19 lymphocytes and natural killer cells.

Impact:

  • Clinical studies in Germany are exploring selenium's efficacy in reducing chemotherapy and radiotherapy side effects.
  • Selenium may enhance patient quality of life by alleviating toxic treatment effects.
  • Potential for selenium to aid in restoring immune function in cancer patients.

Related Concept Videos